Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine

Pediatric Infectious Disease Journal

Volumn 25, Issue 4, 2006, Pages 293-300

  Herz, Arnd M ^a,e   Greenhow, Tara L ^b   Alcantara, Jay ^a   Hansen, John ^c   Baxter, Roger P ^d   Black, Steve B ^c   Shinefield, Henry R ^c  

^a Kaiser Permanente ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Pediatric Vaccine Study Center   (United States)

^d Regional Laboratory   (United States)

^e KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

Bacteremia; Fever; Streptococcus pneumoniae; Toddler (or children); Vaccine

Indexed keywords

HEPTAVALENT CONJUGATED PNEUMOCOCCAL VACCINE; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ARTICLE; BACTEREMIA; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BLOOD CULTURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EMERGENCY WARD; EPIDEMIOLOGICAL DATA; ESCHERICHIA COLI; FEMALE; FEVER; HUMAN; INCIDENCE; INFANT; INFECTION PREVENTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEISSERIA MENINGITIDIS; OUTPATIENT DEPARTMENT; PEDIATRIC HOSPITAL; POPULATION RESEARCH; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALMONELLA; SENSITIVITY AND SPECIFICITY; SEROTYPE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; UNITED STATES; VACCINATION;

BACTEREMIA; CHILD, PRESCHOOL; HUMANS; INCIDENCE; INFANT; MENINGOCOCCAL VACCINES; OUTPATIENTS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 33645537970     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000207485.39112.bf     Document Type: Article

References (26)

1. Lee GM, Harper MB. Risk of bacteremia for febrile young children in the post-Haemophilus influenzae type b era. Arch Pediatr Adolesc Med. 1998;152:624-628.
2. Bandyopadhyay S, Bergholte J, Blackwell CD, et al. Risk of serious bacterial infection in children with fever without a source in the post-Haemophilus influenzae era when antibiotics are reserved for culture-proven bacteremia. Arch Pediatr Adolesc Med. 2002;156:512-517.
3. McGowan JE Jr, Bratton L, Klein JO, et al. Bacteremia in febrile children seen in a "walk-in" pediatric clinic. N Engl J Med. 1973;288:1309-1312.
4. Jaffe DM, Tanz RR, Davis TA, et al. Antibiotic administration to treat possible occult bacteremia in febrile children. N Engl J Med. 1987;317:1175-1180.
5. Dershewitz RA, Wigder HN, Wigder CM. A comparative study of the prevalence, outcome, and prediction of bacteremia in children. J Pediatr. 1083;103:352-358.
6. Ruggeberg JU, Ketteler K, MacKenzie CR, et al. Blood culture sampling rates at a German pediatric university hospital and incidence of invasive pneumococcal disease. Infection. 2004;32:78-81.
7. Baraff LJ, Oslund S, Prather M. Effect of antibiotic therapy and etiologic microorganism on the risk of bacterial meningitis in children with occult bacteremia. Pediatrics. 1993;92:140-143.
8. Shapiro ED, Aaron NH, Wald ER, et al. Risk factors for development of bacterial meningitis among children with occult bacteremia. J Pediatr. 1986;109:15-19.
9. Korones DN, Marshall GS, Shapiro Ed. Outcome of children with occult bacteremia caused by Haemophilus influenzas type b. Pediatr Infect Dis J. 1992;11:516-520.
10. Bachur R, Harper MB. Revaluation of outpatients with Streptococcus pneumoniae bacteremia. Pediatrics. 2000;105:502-509.
11. Baraff LJ, Bass JW, Fleisher GR, et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research. Ann Emerg Med. 1993;22:1198-1210.
12. Young PC. The management of febrile infants by primary-care pediatricians in Utah: comparison with published practice guidelines. Pediatrics. 1995;95:623-627.
13. Isaacman DJ, Shults J, Gross TK. Predictors of bacteremia in febrile children 3 to 36 months of age. Pediatrics. 2000;106:977-982.
14. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children: Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. 2000;19:187-195.
15. Black SB, Shinefield HR, Hansen J, et al. Postlicensure evaluation of the effectiveness of heptavalent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2001;20:1105-1107.
16. Schutze GE, Tucker NC, Mason EO. Impact of the conjugate pneumococcal vaccine in Arkansas. Pediatr Infect Dis J. 2004;23:1125-1129.
17. Black S, Shinefield H, Baxter R, et al. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Pediatr Infect Dis J. 2004;23:485-489.
18. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348:1737-1746.
19. Poehling KA, Lafleur BJ, Szilagyi PG, et al. Population-based impact of pneumococcal conjugate vaccine in young children. Pediatrics. 2004;114:755-761.
20. Kramer MS, Shapiro ED. Management of the young febrile child: a commentary on recent practice guidelines. Pediatrics. 1997;100:128-134.
21. Lee GM, Fleisher GR, Harper MB. Management of febrile children in the age of the conjugate pneumococcal vaccine: a cost-effectiveness analysis. Pediatrics. 2001;108:835-844.
22. Totapally BR, Walsh WT. Pneumococcal bacteremia in childhood: A 6-year experience in a community hospital. Chest. 1998;113:1207-1214.
23. Burke JP, Klein JO, Gezon HM, et al. Pneumococcal bacteremia: review of 111 cases, 1957-1969, with special reference to cases with undetermined focus. Am J Dis Child. 1971;121:353-359.
24. Kline MW, Smith EO, Kaplan SL, et al. Effects of causative organism and presence or absence of meningitis on white blood cell count in children with bacteremia. J Emerg Med. 1988;6:33-35.
25. Steele RW, Garrison N. Fever with bacteremia: a disappearing classic. Consult Pediatr. 2005;4:19-23.
26. Stoll ML, Rubin LG. Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine: a study from a Children's Hospital Emergency Department and Urgent Care Center. Arch Pediatr Adolesc Med. 2004;158:671-675.